|

ADT + Apalutamide Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2/3: 1

Top Sponsors

  • VA Office of Research and Development1

Indications

  • De Novo Prostate Cancer1
  • Oligorecurrence1
  • Oligometastasis1
  • Recurrent Prostate Cancer1
  • Metastatic Prostate Cancer1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.